Financial statements Medicast
Balance sheet data of MEDICAST
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 7 871 380,46 | 7 311 231,56 | 6 883 126,85 | 6 435 876,54 | 6 490 185,00 | 3 927 652,05 |
| A. Fixed assets | 3 219 189,30 | 3 176 481,31 | 3 088 811,56 | 48 207,52 | 15 586,03 | 11 358,98 |
| B. Current assets | 4 652 191,16 | 4 134 750,25 | 3 794 315,29 | 6 387 669,02 | 6 474 598,97 | 3 916 293,07 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | - | - | - | 0,00 | 0,00 |
| Total liabilities | 7 871 380,46 | 7 311 231,56 | 6 883 126,85 | 6 435 876,54 | 6 490 185,00 | 3 927 652,05 |
| A. Equity | 3 341 880,93 | 3 272 302,87 | 3 289 210,09 | 2 755 252,10 | 2 813 892,40 | -1 006 745,61 |
| B. Liabilities and provisions for liabilities | 4 529 499,53 | 4 038 928,69 | 3 593 916,76 | 3 680 624,44 | 3 676 292,60 | 4 934 397,66 |
| I. Long-term liabilities | 1 992 150,71 | 1 992 150,71 | 2 386 660,71 | 2 135 767,51 | 1 858 150,71 | 0,00 |
| II. Short-term liabilities | 2 389 136,29 | 1 936 466,41 | 1 111 426,11 | 1 327 205,80 | 1 812 762,98 | 4 924 888,99 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.